Article
ACTH-receptor deficient mutants of the Y1 mouse adrenocortical tumor cell line.
Endocrine research - 1 Jan 2000
Schimmer B P, Kwan W K, Tsao J, Qiu R
Abstract excerpt
Two mutant clones (Y6 and OS3) derived from the ACTH-responsive Y1 mouse adrenocortical tumor cell line fail to respond to ACTH with increased adenylyl cyclase activity and, as a consequence, are resistant to the steroidogenic effects of the hormone. As determined from Northern blot and RNase protection assays, ACTH resistance in these mutants results from the failure to accumulate ACTH receptor transcripts. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
